Research and practice in thrombosis and haemostasis · 2025
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Calcaterra Ilenia Lorenza, Picasso Federico, Valeri Federica, Baldacci Erminia, Napolitano Mariasanta, Guerrino Cornelia, Zanon Ezio, Santoro Cristina, Siragusa Sergio, Martinoli Carlo, Di Minno Matteo Nicola Dario
Аннотация
BACKGROUND: The prevalence of arthropathy in people with moderate hemophilia A (mHA) is highly variable. People with mHA are often undertreated, and this may lead to joint damage and worsen their quality of life.
OBJECTIVES: The aim of the present study was to evaluate joint status in mHA by means of point-of-care ultrasound (PoCUS) and clinical examination.
METHODS: Consecutive people with mHA receiving on-demand replacement treatment underwent a clinical examination of joint status according to the Hemophilia Joint Health Score (HJHS) protocol. On the same day, all patients underwent a PoCUS assessment according to the Hemophilia Early Detection by UltraSound (HEAD-US) protocol.
RESULTS: A total of 51 subjects were included. The median HJHS score was 2.0 (IQR, 0-3.0). A 0 to 1 HJHS score was found in 23 people with mHA (45.1%), between 2 and 3 in 17 (33.3%) and >3 in 11 (21.6%). The median HEAD-US score was 2.0 (IQR, 1-7), and a statistically significant correlation between HJHS and HEAD-US was found (rho = 0.732; P < .001). Osteochondral damage was found in 21.6% of patients, and hypertrophic synovium (HS) was found in 29.4%. Among those reporting a 0 to 1 HJHS score, 13.0% showed HS. Analysis at the joint level showed that the most commonly affected joint was the ankle, both for osteochondral damage and the presence of HS.
CONCLUSION: Our study suggests that the prevalence of arthropathy changes in people with mHA receiving on-demand treatment is not negligible and that PoCUS is able to detect osteochondral damage as well as HS in this clinical setting. A more extensive screening of the joint status could be useful to tailor treatment and improve outcomes in mHA.
OBJECTIVES: The aim of the present study was to evaluate joint status in mHA by means of point-of-care ultrasound (PoCUS) and clinical examination.
METHODS: Consecutive people with mHA receiving on-demand replacement treatment underwent a clinical examination of joint status according to the Hemophilia Joint Health Score (HJHS) protocol. On the same day, all patients underwent a PoCUS assessment according to the Hemophilia Early Detection by UltraSound (HEAD-US) protocol.
RESULTS: A total of 51 subjects were included. The median HJHS score was 2.0 (IQR, 0-3.0). A 0 to 1 HJHS score was found in 23 people with mHA (45.1%), between 2 and 3 in 17 (33.3%) and >3 in 11 (21.6%). The median HEAD-US score was 2.0 (IQR, 1-7), and a statistically significant correlation between HJHS and HEAD-US was found (rho = 0.732; P < .001). Osteochondral damage was found in 21.6% of patients, and hypertrophic synovium (HS) was found in 29.4%. Among those reporting a 0 to 1 HJHS score, 13.0% showed HS. Analysis at the joint level showed that the most commonly affected joint was the ankle, both for osteochondral damage and the presence of HS.
CONCLUSION: Our study suggests that the prevalence of arthropathy changes in people with mHA receiving on-demand treatment is not negligible and that PoCUS is able to detect osteochondral damage as well as HS in this clinical setting. A more extensive screening of the joint status could be useful to tailor treatment and improve outcomes in mHA.